MedTrace Logo

Hormonal Deficiency in the Quality of Life of Patients With Traumatic Brain Injury

NCT01512524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2025-12-19

No results posted yet for this study

Summary

The primary objective is to assess the long-term impact of hormonal deficiency on Quality of Life (QoL) in a large group of moderate and severe Traumatic Brain Injury (TBI) patients.

Conditions

  • Traumatic Brain Injury (TBI)

Interventions

OTHER

MRI scan and endocrinology analysis

Endocrinology analysis including statique and dynamic exams, neuropsychologic evaluations and IRM scan.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Sophie Courtois, MD · Hôpital Henry Gabrielle, Hospices Civils de Lyon

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-23
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01512524 on ClinicalTrials.gov